Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Controlled Substances – Clarification on Rules for Promotional and Informational Materials
-
Hi,
Are controlled drugs listed under Schedule I of the Controlled Drugs and Substances Act subject to the same marketing and advertising regulations as opioids?
Is it permissible to create and provide promotional materials for controlled drugs to healthcare professionals or medical staff?
If not, can product fact sheets still be distributed? -
This post was answered through our office earlier but we will post the answers here as well.
- No, only opioids are subject to the Health Canada terms and conditions for advertising.
- It is permissible to create promotional materials to HCPs for a controlled drug. However, note that direct to consumer advertising is not permitted.
-
A ALee referenced this topic
